Extracellular vesicles in glioblastoma: Role in biological processes and in therapeutic applications

Current Cancer Drug Targets

Volumn 17, Issue 3, 2017, Pages 221-235

  Giusti, Ilaria ^a   Di Francesco, Marianna ^a   Dolo, Vincenza ^a  

^a UNIVERSITY OF L'AQUILA   (Italy)

Author keywords

Cells irradiation; Exosomes; Extracellular vesicles; Glioblastoma; Glioblastoma markers; Microvesicles; U251 cells

Indexed keywords

MICRORNA;

BRAIN NEOPLASMS; CELL MOTION; CELL PROLIFERATION; EXOSOME; GLIOBLASTOMA; HUMAN; METABOLISM; NEOVASCULARIZATION (PATHOLOGY); PATHOLOGY; PHYSIOLOGY;

BRAIN NEOPLASMS; CELL MOVEMENT; CELL PROLIFERATION; EXOSOMES; EXTRACELLULAR VESICLES; GLIOBLASTOMA; HUMANS; MICRORNAS; NEOVASCULARIZATION, PATHOLOGIC;

EID: 85010451112     PISSN: 15680096     EISSN: 18735576     Source Type: Journal    
DOI: 10.2174/1568009616666160813182959     Document Type: Review

References (142)

1. Veliz, I.; Loo, Y.; Castillo, O.; Karachaliou, N.; Nigro, O.; Rosell, R. Advances and challenges in the molecular biology and treatment of glioblastoma-is there any hope for the future? Ann. Transl. Med., 2015, 3(1), 7.
2. Akers, J.C.; Ramakrishnan, V.; Kim, R.; Skog, J.; Nakano, I.; Pingle, S.; Kalinina, J.; Hua, W.; Kesari, S.; Mao, Y.; Breakefield, X.O.; Hochberg, F.H.; Van Meir, E.G.; Carter, B.S.; Chen, C.C. MiR-21 in the extracellular vesicles (EVs) of cerebrospinal fluid (CSF): a platform for glioblastoma biomarker development. PLoS. One, 2013, 8(10), e78115.
3. Weller, M.; van den Bent, M.; Hopkins, K.; Tonn, J.C.; Stupp, R.; Falini, A.; Cohen-Jonathan-Moyal, E.; Frappaz, D.; Henriksson, R.; Balana, C.; Chinot, O.; Ram, Z.; Reifenberger, G.; Soffietti, R.; Wick, W. EANO guideline for the diagnosis and treatment of anaplastic gliomas and glioblastoma. Lancet Oncol., 2014, 15(9), e395-e403.
4. Agnihotri, S.; Burrell, K.E.; Wolf, A.; Jalali, S.; Hawkins, C.; Rutka, J.T.; Zadeh, G. Glioblastoma, a brief review of history, molecular genetics, animal models and novel therapeutic strategies. Arch. Immunol. Ther. Exp. (Warsz)., 2013, 61(1), 25-41.
5. Hochberg, F.H.; Atai, N.A.; Gonda, D.; Hughes, M.S.; Mawejje, B.; Balaj, L.; Carter, R.S. Glioma diagnostics and biomarkers: an ongoing challenge in the field of medicine and science. Expert Rev. Mol. Diagn., 2014, 14(4), 439-452.
6. Furnari, F.B.; Fenton, T.; Bachoo, R.M.; Mukasa, A.; Stommel, J.M.; Stegh, A.; Hahn, W.C.; Ligon, K.L.; Louis, D.N.; Brennan, C.; Chin, L; DePinho, R.A.; Cavenee, W.K. Malignant astrocytic glioma: genetics, biology, and paths to treatment. Genes. Dev., 2007, 21(21), 2683-2710.
7. Lathia, J.D.; Heddleston, J.M.; Venere, M.; Rich, J.N. Deadly teamwork: neural cancer stem cells and the tumor microenvironment. Cell Stem Cell, 2011, 8(5), 482-485.
8. Bronisz, A.; Wang, Y.; Nowicki, M.O.; Peruzzi, P.; Ansari, K.I.; Ogawa, D.; Balaj, L.; De Rienzo, G.; Mineo, M.; Nakano, I.; Ostrowski, M.C.; Hochberg, F.; Weissleder, R.; Lawler, S.E.; Chiocca, E.A.; Godlewski, J. Extracellular vesicles modulate the glioblastoma microenvironment via a tumor suppression signaling network directed by miR-1. Cancer Res., 2014, 74(3), 738-750.
9. Lee, S. G.; Kim, K.; Kegelman, T.P.; Dash, R.; Das, S.K.; Choi, J.K.; Emdad, L.; Howlett, E.L; Jeon, H.Y.; Su, Z.Z.; Yoo, B.K.; Sarkar, D.; Kim, S.H.; Kang, D.C.; Fisher, P.B. Oncogene AEG-1 promotes glioma-induced neurodegeneration by increasing glutamate excitotoxicity. Can. Res., 2011, 71(20), 6514-6523.
10. Sontheimer, H. A role for glutamate in growth and invasion of primary brain tumors. J. Neurochem., 2008, 105(2), 287-295.
11. Skog, J.; Wurdinger, T.; van Rijn, S.; Meijer, D.H.; Gainche, L.; Sena-Esteves, M.; Curry, W.T. Jr.; Carter, B.S.; Krichevsky, A.M.; Breakefield, X.O. Glioblastoma microvesicles transport RNA and proteins that promote tumour growth and provide diagnostic biomarkers. Nat. Cell. Biol., 2008, 10(12), 1470-1476.
12. Nakano, I.; Garnier, D.; Minata, M.; Rak, J. Extracellular vesicles in the biology of brain tumours stem cells-Implications for intercellular communication, therapy and biomarker development. Semin. Cell Dev. Biol., 2015, pii, S1084-9521(15)00038-5.
13. Mause, S.F.; Weber, C. Microparticles: protagonists of a novel communication network for intercellular information exchange. Circ. Res., 2010, 107(9), 1047-1057.
14. Schifferli, J.A. Microvesicles are messengers. Semin. Immunopathol., 2011, 33(5), 393-394.
15. Shifrin, D.A. Jr; Demory Beckler, M.; Coffey, R.J.; Tyska, M.J. Extracellular vesicles: communication, coercion, and conditioning. Mol. Biol. Cell, 2013, 24(9), 1253-1259.
16. Tetta, C.; Ghigo, E.; Silengo, L.; Deregibus, M.C.; Camussi, G. Extracellular vesicles as an emerging mechanism of cell-to-cell communication. Endocrine, 2013, 44(1), 11-19.
17. Collino, F.; Deregibus, M.C.; Bruno, S.; Sterpone, L.; Aghemo, G.; Viltono, L.; Tetta, C.; Camussi, G. Microvesicles derived from adult human bone marrow and tissue specific mesenchymal stem cells shuttle selected pattern of miRNAs. PLoS One., 2010, 5(7), e11803.
18. Del Conde, I.; Shrimpton, C.N.; Thiagarajan, P.; Lopez, J.A. Tissue-factor-bearing microvesicles arise from lipid rafts and fuse with activated platelets to initiate coagulation. Blood, 2005, 106(5), 1604-1611.
19. Obregon, C.; Rothen-Rutishauser, B.; Gitahi, S.K.; Gehr, P.; Nicod, L.P. Exovesicles from human activated dendritic cells fuse with resting dendritic cells, allowing them to present alloantigens. Am. J. Pathol., 2006, 169(6), 2127-2136.
20. Inal, J.M.; Ansa-Addo, E.A.; Stratton, D.; Kholia, S.; Antwi-Baffour, S.S.; Jorfi, S.; Lange, S. Microvesicles in health and disease. Arch. Immunol. Ther. Exp. (Warsz)., 2012, 60(2), 107-121.
21. Corrado, C.; Raimondo, S.; Chiesi, A.; Ciccia, F.; De Leo, G.; Alessandro, R. Exosomes as intercellular signaling organelles involved in health and disease: basic science and clinical applications. Int. J. Mol. Sci., 2013, 14(3), 5338-5366.
22. Gyorgy, B.; Szabo, T.G.; Pasztoi, M.; Pal, Z.; Misjak, P.; Aradi, B.; Laszlo, V.; Pallinger, E.; Pap, E.; Kittel, A.; Nagy, G.; Falus, A.; Buzas, E.I. Membrane vesicles, current state-of-the-art: emerging role of extracellular vesicles. Cell. Mol. Life. Sci., 2011, 68(16), 2667-2688.
23. Gould, S.J.; Raposo, G. As we wait: coping with an imperfect nomenclature for extracellular vesicles. J. Extracell. Vesicles., 2013, 2. doi: 10.3402/jev.v2i0.20389.
24. Turturici, G.; Tinnirello, R.; Sconzo, G.; Geraci, F. Extracellular membrane vesicles as a mechanism of cell-to-cell communication: advantages and disadvantages. Am. J. Physiol. Cell Physiol., 2014, 306(7), C621-633.
25. Dolo, V.; D’Ascenzo, S.; Giusti, I.; Millimaggi, D.; Taraboletti, G.; Pavan, A. Shedding of membrane vesicles by tumor and endothelial cells. Ital. J. Anat. Embryol., 2005, 110(2 Suppl 1), 127-133.
26. Janowska-Wieczorek, A.; Wysoczynski, M.; Kijowski, J.; Marquez-Curtis, L.; Machalinski, B.; Ratajczak, J.; Ratajczak, M.Z. Microvesicles derived from activated platelets induce metastasis and angiogenesis in lung cancer. Int. J. Cancer, 2005, 113, 752-760.
27. Luga, V.; Zhang, L.; Viloria-Petit, A.M.; Ogunjimi, A.A.; Inanlou, M.R.; Chiu, E.; Buchanan, M.; Hosein, A.N.; Basik, M.; Wrana, J.L. Exosomes mediate stromal mobilization of autocrine Wnt-PCP signalin in breast cancer cell migration. Cell, 2012, 151(7), 1542-1556.
28. Kucharzewska, P.; Belting, M. Emerging roles of extracellular vesicles in the adaptive response of tumour cells to microenvironmental stress. J. Extracell. Vesicles, 2013, 2. doi: 10.3402/jev.v2i0.20304.
29. Raposo, G.; Stoorvogel, W. Extracellular vesicles: exosomes, microvesicles, and friends. J. Cell Biol., 2013, 200(4), 373-383.
30. Witwer, K.W.; Buzas, E.I.; Bemis, L.T.; Bora, A.; Lasser, C.; Lotvall, J.; Nolte-’t Hoen, E.N.; Piper, M.G.; Sivaraman, S.; Skog, J.; Thery, C.; Wauben, M.H.; Hochberg, F. Standardization of sample collection, isolation and analysis methods in extracellular vesicle research. J. Extracell. Vesicles., 2013, 2. doi: 10.3402/jev.v2i0.20360.
31. Salih, M.; Zietse, R.; Hoorn, E.J. Urinary extracellular vesicles and the kidney: biomarkers and beyond. Am. J. Physiol. Renal. Physiol., 2014, 306(11), F1251-1259.
32. Aalberts, M.; van Dissel-Emiliani, F.M.; van Adrichem N.P.; van Wijnen M.; Wauben M.H.; Stout T.A.; Stoorvogel W. Identification of distinct populations of prostasomes that differentially express prostate stem cell antigen, annexin A1, and GLIPR2 in humans. Biol. Reprod., 2012, 86(3), 82.
33. Admyre, C.; Johansson S.M.; Qazi K.R.; Filen J.J.; Lahesmaa R.; Norman M.; Neve E.P.; Scheynius, A.; Gabrielsson S. Exosomes with immune modulatory features are present in human breast milk. J. Immunol., 2007, 179, 1969-1978.
34. Keller, S.; Rupp, C.; Stoeck, A.; Runz, S.; Fogel, M.; Lugert, S.; Hager, H.D.; Abdel-Bakky, M.S.; Gutwein, P.; Altevogt, P. CD24 is a marker of exosomes secreted into urine and amniotic fluid. Kidney Int., 2007, 72(9), 1095-1102.
35. Mincheva-Nilsson, L.; Baranov, V. Placenta-derived exosomes and their role in the immune protection of the fetus. In: Recent Advances in Research on the Human Placent, Jing, Z., Ed.; InTech: Croatia, 2012; pp. 243-262.
36. Harding, C.; Heuser, J.; Stahl, P. Receptor-mediated endocytosis of transferrin and recycling of the transferrin receptor in rat reticulocytes. J. Cell. Biol., 1983, 97(2), 329-339.
37. Heijnen, H.F.; Schiel, A.E.; Fijnheer, R.; Geuze, H.J.; Sixma, J.J. Activated platelets release two types of membrane vesicles: microvesicles by surface shedding and exosomes derived from exocytosis of multivesicular bodies and alpha-granules. Blood, 1999, 94(11), 3791-3799.
38. Mathivanan, S.; Ji, H.; Simpson, R. Exosomes: Extracellular organelles important in intercellular communication. J. Proteomics, 2010, 73(10), 1907-1920.
39. Simons, M., Raposo, G. Exosomes-vesicular carriers for intercellular communication. Curr. Opin. Cell Biol., 2009, 21(4), 575-581.
40. Colombo, M.; Moita, C.; van Niel, G.; Kowal, J.; Vigneron, J.; Benaroch, P.; Manel, N.; Moita, L.F.; Thery, C.; Raposo, G. Analysis of ESCRT functions in exosome biogenesis, composition and secretion highlights the heterogeneity of extracellular vesicles. J. Cell. Sci., 2013, 126(Pt 24), 5553-5565.
41. Trajkovic, K.; Hsu, C.; Chiantia, S.; Rajendran, L.; Wenzel, D.; Wieland, F.; Schwille, P.; Brugger, B.; Simons, M. Ceramide triggers budding of exosome vesicles into multivesicular endosomes. Science, 2008, 319, 1244-1247.
42. Ostrowski, M.; Carmo, N.B.; Krumeich, S.; Fanget, I.; Raposo, G.; Savina, A.; Moita, C.F.; Schauer, K.; Hume, A.N.; Freitas, R.P.; Goud, B.; Benaroch, P.; Hacohen, N.; Fukuda, M.; Desnos, C.; Seabra, M.C.; Darchen, F.; Amigorena, S.; Moita, L.F.; Thery, C. Rab27a and Rab27b control different steps of the exosome secretion pathway. Nat. Cell Biol., 2010, 12(1), 19-30.
43. van Doormaal, F.F.; Kleinjan, A.; Di Nisio, M.; Buller, H.R.; Nieuwland, R. Cell-derived microvesicles and cancer. Neth. J. Med., 2009, 67(7), 266-273.
44. Muralidharan-Chari, V.; Clancy, J.W.; Sedgwick, A.; D’Souza-Schorey, C. Microvesicles: mediators of extracellular communication during cancer progression. J. Cell Sci., 2010, 123(Pt 10), 1603-1611.
45. Barteneva, N.S.; Fasler-Kan, E.; Bernimoulin, M.; Stern, J.N.; Ponomarev, E.D.; Duckett, L.; Vorobjev, I.A. Circulating microparticles: square the circle. BMC. Cell. Biol., 2013, 14, 23.
46. Muralidharan-Chari, V.; Clancy J.; Plou, C.; Romao, M.; Chavrier, P.; Raposo, G.; D’Souza-Schorey, C. ARF6-regulated shedding of tumor-cell derived plasma membrane microvesicles. Curr. Biol., 2009, 19(22), 1875-1885.
47. D’Souza-Schorey, C.; Clancy, J.W. Tumor-derived microvesicles: shedding light on novel microenvironment modulators and prospective cancer biomarkers. Genes Dev., 2012, 26(12), 1287-1299.
48. Vader, P.; Breakefield, X.O.; Wood, M.J. Extracellular vesicles: emerging targets for cancer therapy. Trends Mol. Med., 2014, 20(7), 385-393.
49. Keerthikumar, S.; Gangoda, L.; Liem, M.; Fonseka, P.; Atukorala, I.; Ozcitti, C.; Mechler, A.; Adda, C.G.; Ang, C.S.; Mathivanan S. Proteogenomic analysis reveals exosomes are more oncogenic than ectosomes. Oncotarget., 2015, 6(17), 15375-15396.
50. Cocucci, E.; Racchetti, G.; Meldolesi, J. Shedding microvesicles: artefacts no more. Trends Cell. Biol., 2009, 19(2), 43-51.
51. Antonyak, M.A.; Li, B.; Boroughs, L.K.; Johnson, J.L.; Druso, J.E.; Bryant, K.L.; Holowka, D.A.; Cerione, R.A. Cancer cellderived microvesicles induce transformation by transferring tissue transglutaminase and fibronectin to recipient cells. Proc. Natl. Acad. Sci. U S A., 2011, 108(12), 4852-4857.
52. Borges, F.T.; Reis, L.A.; Schor, N. Extracellular vesicles: structure, function, and potential clinical uses in renal diseases. Braz. J. Med. Biol. Res., 2013, 46(10), 824-830.
53. Kowal, J.; Tkach, M.; Thery, C. Biogenesis and secretion of exosomes. Curr. Opin. Cell. Biol., 2014, 29, 116-125.
54. Khan, S.; Jutzy, J.M.S.; Aspe, J.R.; Valenzuela, M.M.A.; Park, J.S.; Turay, D.; Wall, N.R. The application of membrane vesicles for cancer therapy. In: Advances in Cancer Therapy, Gali-Muhtasib, P.H., Ed.; InTech: Croatia, 2011; pp. 21-52.
55. EL Andaloussi, S.; Mager, I.; Breakefield, X.O.; Wood, M.J. Extracellular vesicles: biology and emerging therapeutic opportunities. Nat. Rev. Drug Discov., 2013, 12(5), 347-57.
56. Robbins, P.D.; Morelli, A.E. Regulation of immune responses by extracellular vesicles. Nat. Rev. Immunol., 2014, 14(3), 195-208.
57. Owens, A.P. 3rd, Mackman, N. Microparticles in hemostasis and thrombosis. Circ. Res., 2011, 108(10), 1284-1297.
58. Fruhbeis, C.; Frohlich, D.; Kuo, W.P.; Kramer-Albers, E.M. Extracellular vesicles as mediators of neuron-glia communication. Front. Cell. Neurosci., 2013, 7: 182.
59. Tetta, C.; Consiglio, A.L.; Bruno, S.; Tetta, E.; Gatti, E.; Dobreva, M.; Cremonesi, F.; Camussi, G. The role of microvesicles derived from mesenchymal stem cells in tissue regeneration; a dream for tendon repair? Muscles Ligaments Tendons J., 2012, 2(3), 212-221.
60. De Jong, O.G.; Van Balkom, B.W.; Schiffelers, R.M.; Bouten, C.V.; Verhaar, M.C. Extracellular vesicles: potential roles in regenerative medicine. Front. Immunol., 2014, 5, 608.
61. Gaceb, A.; Martinez, M.C.; Andriantsitohaina, R. Extracellular vesicles: new players in cardiovascular diseases. Int. J. Biochem. Cell Biol., 2014, 50, 24-28.
62. Buzas, E.I.; Gyorgy, B.; Nagy, G.; Falus, A.; Gay, S. Emerging role of extracellular vesicles in inflammatory diseases. Nat. Rev. Rheumatol., 2014, 10(6), 356-364.
63. Candelario, K.M.; Steindler, D.A. The role of extracellular vesicles in the progression of neurodegenerative disease and cancer. Trends Mol. Med., 2014, 20(7), 368-374.
64. Kim, H.K.; Song, K.S.; Park, Y.S.; Kang, Y.H.; Lee, Y.J.; Lee, K.R.; Kim, H.K.; Ryu, K.W.; Bae, J.M.; Kim, S. Elevated levels of circulating platelet microparticles, VEGF, IL-6 and RANTES in patients with gastric cancer: possible role of a metastasis predictor. Eur. J. Cancer, 2003, 39(2), 184-191.
65. Peinado, H.; Lavotshkin, S.; Lyden, D. The secreted factors responsible for pre-metastatic niche formation: old sayings and new thoughts. Semin. Cancer Biol., 2011, 21(2), 139-146.
66. Ge, R.; Tan, E.; Sharghi-Namini, S.; Asada, H.H. Exosomes in cancer microenvironment and beyond: have we overlooked these extracellular messengers? Cancer Microenviron., 2012, 5(3), 323-332.
67. Webber, J.; Steadman, R.; Mason, M.D.; Tabi, Z.; Clayton, A. Cancer exosomes trigger fibroblast to myofibroblast differentiation. Cancer Res., 2010, 70(23), 9621-9630.
68. Luga, V.; Zhang, L.; Viloria-Petit, A.M.; Ogunjimi, A.A.; Inanlou, M.R.; Chiu, E.; Buchanan, M.; Hosein, A.N.; Basik, M.; Wrana, J.L. Exosomes mediate stromal mobilization of autocrine Wnt-PCP signaling in breast cancer cell migration. Cell, 2012, 151(7), 1542-1556.
69. Weis, S.M.; Cheresh, D.A. Tumor angiogenesis: molecular pathways and therapeutic targets. Nat. Med., 2011, 17(11), 1359-1370.
70. Millimaggi, D.; Mari, M.; D’Ascenzo, S.; Carosa, E.; Jannini, E.A.; Zucker, S.; Carta, G.; Pavan, A.; Dolo, V. Tumor vesicleassociated CD147 modulates the angiogenic capability of endothelial cells. Neoplasia, 2007, 9(4), 349-357.
71. Al-Nedawi, K.; Meehan, B.; Kerbel, R.S.; Allison, A.C.; Rak, J. Endothelial expression of autocrine VEGF upon the uptake of tumor-derived microvesicles containing oncogenic EGFR. Proc. Natl. Acad. Sci. USA, 2009, 106(10), 3794-3799.
72. Hong, B.S.; Cho, J.H.; Kim, H.; Choi, E.J.; Rho, S.; Kim, J.; Kim, J.H.; Choi, D.S.; Kim, Y.K.; Hwang, D.; Gho, Y.S. Colorectal cancer cell-derived microvesicles are enriched in cell cycle-related mRNAs that promote proliferation of endothelial cells. BMC. Genomics, 2009, 10, 556.
73. Kosaka, N.; Iguchi, H.; Hagiwara, K.; Yoshioka, Y.; Takeshita, F.; Ochiya, T. Neutral sphingomyelinase 2 (nSMase2)-dependent exosomal transfer of angiogenic microRNAs regulate cancer cell metastasis. J. Biol. Chem., 2013, 288(15), 10849-10859.
74. Zhuang, G.; Wu, X.; Jiang, Z.; Kasman, I.; Yao, J.; Guan, Y.; Oeh, J.; Modrusan, Z.; Bais, C.; Sampath, D.; Ferrara N. Tumoursecreted miR-9 promotes endothelial cell migration and angiogenesis by activating the JAK-STAT pathway. EMBO J., 2012, 31(17), 3513-3523.
75. Dolo, V.; D’Ascenzo, S.; Violini, S.; Pompucci, L.; Festuccia, C.; Ginestra, A.; Vittorelli, M.L.; Canevari, S.; Pavan, A. Matrixdegrading proteinases are shed in membrane vesicles by ovarian cancer cells in vivo and in vitro. Clin. Exp. Metastasis, 1999, 17(2), 131-140.
76. Dolo, V.; Ginestra, A.; Cassara, D.; Ghersi, G.; Nagase, H.; Vittorelli, M.L. Shed membrane vesicles and selective localization of gelatinases and MMP-9/TIMP-1 complexes. Ann. NY. Acad. Sci., 1999, 878, 497-499.
77. Angelucci, A.; D’Ascenzo, S.; Festuccia, C.; Gravina, G.L.; Bologna, M.; Dolo, V.; Pavan, A. Vesicle-associated urokinase plasminogen activator promotes invasion in prostate cancer cell lines. Clin. Exp. Metastasis, 2000, 18(2), 163-170.
78. Giusti, I.; D’Ascenzo, S.; Millimaggi, D.; Taraboletti, G.; Carta, G.; Franceschini, N.; Pavan, A.; Dolo, V. Cathepsin B mediates the pH-dependent proinvasive activity of tumor-shed microvesicles. Neoplasia, 2008, 10(5), 481-488.
79. Andreola, G.; Rivoltini, L.; Castelli, C.; Huber, V.; Perego, P.; Deho, P.; Squarcina, P.; Accornero, P.; Lozupone, F.; Lugini, L.; Stringaro, A.; Molinari, A.; Arancia, G.; Gentile, M.; Parmiani, G.; Fais, S. Induction of lymphocyte apoptosis by tumor cell secretion of FasL-bearing microvesicles. J. Exp. Med., 2002, 195(10), 1303-1316.
80. Abusamra, A.J.; Zhong, Z.; Zheng, X.; Li, M.; Ichim, T.E.; Chin, J.L.; Min, W.P. Tumor exosomes expressing Fas ligand mediate CD8+ T-cell apoptosis. Blood Cells Mol. Dis., 2005, 35(2), 169-173.
81. Clayton, A.; Mitchell, J.P.; Court, J.; Linnane, S.; Mason, M.D.; Tabi, Z. Human tumor-derived exosomes down-modulate NKG2D expression. J. Immunol., 2008, 180(11), 7249-7258.
82. Abid Hussein, M.N.; Boing, A.N.; Sturk, A.; Hau, C.M.; Nieuwland, R. Inhibition of microparticle release triggers endothelial cell apoptosis and detachment. Thromb. Haemost., 2007, 98(5), 1096-1107.
83. Bebawy, M.; Combes, V.; Lee, E.; Jaiswal, R.; Gong, J.; Bonhoure, A.; Grau, G.E. Membrane microparticles mediate transfer of Pglycoprotein to drug sensitive cancer cells. Leukemia, 2009, 23(9), 1643-1649.
84. Lv, M.M.; Zhu, X.Y.; Chen, W.X.; Zhong, S.L.; Hu, Q.; Ma, T.F.; Zhang, J.; Chen, L.; Tang, J.H.; Zhao, J.H. Exosomes mediate drug resistance transfer in MCF-7 breast cancer cells and a probable mechanism is delivery of P-glycoprotein. Tumour Biol., 2014, 35(11), 10773-10779.
85. Chen, W.X.; Cai, Y.Q.; Lv, M.M.; Chen, L.; Zhong, S.L.; Ma, T.F.; Zhao, J.H.; Tang, J.H. Exosomes from docetaxel-resistant breast cancer cells alter chemosensitivity by delivering microRNAs. Tumour Biol., 2014, 35(10), 9649-9659.
86. Hood, J.L.; San, R.S.; Wickline, S.A. Exosomes released by melanoma cells prepare sentinel lymph nodes for tumor metastasis. Cancer Res., 2011, 71(11), 3792-3801.
87. Grange, C.; Tapparo, M.; Collino, F.; Vitillo, L.; Damasco, C.; Deregibus, M.C.; Tetta, C.; Bussolati, B.; Camussi, G. Microvesicles released from human renal cancer stem cells stimulate angiogenesis and formation of lung premetastatic niche. Cancer Res., 2011, 71(15), 5346-5356.
88. Fong, M.Y.; Zhou, W.; Liu, L.; Alontaga, A.Y.; Chandra, M.; Ashby, J.; Chow, A.; O’Connor, S.T.; Li, S.; Chin, A.R.; Somlo, G.; Palomares, M.; Li, Z.; Tremblay, J.R.; Tsuyada, A.; Sun, G.; Reid, M.A.; Wu, X.; Swiderski, P.; Ren, X.; Shi, Y.; Kong, M.; Zhong, W.; Chen, Y.; Wang, S.E. Breast-cancer-secreted miR-122 reprograms glucose metabolism in premetastatic niche to promote metastasis. Nat. Cell. Biol., 2015, 17(2), 183-194.
89. Tominaga, N.; Kosaka, N.; Ono, M.; Katsuda, T.; Yoshioka, Y.; Tamura, K.; Lotvall, J.; Nakagama, H.; Ochiya, T. Brain metastatic cancer cells release microRNA-181c-containing extracellular vesicles capable of destructing blood-brain barrier. Nat. Commun., 2015, 6, 716.
90. Costa-Silva, B.; Aiello, N.M.; Ocean, A.J.; Singh, S.; Zhang, H.; Thakur, B.K.; Becker, A.; Hoshino, A.; Mark, M.T.; Molina, H.; Xiang, J.; Zhang, T.; Theilen, T. M.; Garcia-Santos, G.; Williams, C.; Ararso, Y.; Huang, Y.; Rodrigues, G.; Shen, T.L.; Labori, K.J.; Lothe, I.M.; Kure, E.H.; Hernandez, J.; Doussot, A.; Ebbesen, S.H.; Grandgenett, P.M.; Hollingsworth, M.A.; Jain, M.; Mallya, K.; Batra, S.K.; Jarnagin, W.R.; Schwartz, R.E.; Matei, I.; Peinado, H.; Stanger, B.Z.; Bromberg, J.; Lyden, D. Pancreatic cancer exosomes initiate pre-metastatic niche formation in the liver. Nat. Cell. Biol., 2015, 17(6), 816-826.
91. Godlewski, J.; Krichevsky, A.M.; Johnson, M.D.; Chiocca, E.A.; Bronisz, A. Belonging to a network-microRNAs, extracellular vesicles, and the glioblastoma microenvironment. Neuro. Oncol., 2015, 17(5), 652-662.
92. van der Vos, K.E.; Balaj, L.; Skog, J.; Breakefield, X.O. Brain tumor microvesicles: insights into intercellular communication in the nervous system. Cell. mol. Neurobiol., 2011, 31(6), 949-959.
93. Chistiakov, D.A.; Chekhonin, V.P. Extracellular vesicles shed by glioma cells: pathogenic role and clinical value. Tumour Biol., 2014, 35(9), 8425-8438.
94. Li, C.C.; Eaton, S.A.; Young, P.E.; Lee, M.; Shuttleworth, R.; Humphreys, D.T.; Grau, G.E.; Combes, V.; Bebawy, M.; Gong, J.; Brammah, S.; Buckland, M.E.; Suter, C.M. Glioma microvesicles carry selectively packaged coding and non-coding RNAs which alter gene expression in recipient cells. RNA Biol., 2013, 10(8), 1333-1344.
95. Valadi, H.; Ekstrom, K.; Bossios, A.; Sjostrand, M.; Lee, J.J.; Lotvall, J.O. Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells. Nat. Cell. Biol., 2007, 9(6), 654-659.
96. Kucharzewska, P.; Christianson, H.C.; Welch, J.E.; Svensson, K.J.; Fredlund, E.; Ringner, M.; Morgelin, M.; Bourseau-Guilmain, E.; Bengzon, J.; Belting, M. Exosomes reflect the hypoxic status of glioma cells and mediate hypoxia-dependent activation of vascular cells during tumor development. Proc. Natl. Acad. Sci. USA, 2013, 110(18), 7312-7317.
97. Paul, I.; Bhattacharya, S.; Chatterjee, A.; Ghosh, M.K. Current understanding on EGFR and Wnt/β-Catenin signaling in glioma and their possible crosstalk. Genes Cancer, 2013, 4(11-12), 427-446.
98. Setti, M.; Osti, D.; Richichi, C.; Ortensi, B.; Del Bene, M.; Fornasari, L.; Beznoussenko, G.; Mironov, A.; Rappa, G.; Cuomo, A.; Faretta, M.; Bonaldi, T.; Lorico, A.; Pelicci, G. Extracellular vesicle-mediated transfer of CLIC1 protein is a novel mechanism for the regulation of glioblastomagrowth. Oncotarget., 2015, 6(31), 31413-31427.
99. Yang, L.; Lin, C.; Wang, L.; Guo, H.; Wang, X. Hypoxia and hypoxia-inducible factors in glioblastoma multiforme progression and therapeutic implications. Exp. Cell. Res., 2012, 318(19), 2417-2426.
100. Svensson, K.J.; Kucharzewska, P.; Christianson, H.C.; Skold, S.; Lofstedt, T.; Johansson, M.C.; Morgelin, M.; Bengzon, J.; Ruf, W.; Belting, M. Hypoxia triggers a proangiogenic pathway involving cancer cell microvesicles and PAR-2-mediated heparin-binding EGF signaling in endothelial cells. Proc. Natl. Acad. Sci. USA, 2011, 108(32), 13147-13152.
101. Jiang, L.; Lin, C.; Song, L.; Wu, J.; Chen, B.; Ying, Z.; Fang, L.; Yan, X.; He, M.; Li, J.; Li, M. MicroRNA-30e* promotes human glioma cell invasiveness in an orthotopic xenotransplantation model by disrupting the NF-κB/IκBα negative feedback loop. J. Clin. Invest., 2012, 122(1), 33-47.
102. Wang, J.; Wang, Y.; Wang, Y.; Ma, Y.; Lan, Y.; Yang, X. Transforming growth factor β-regulated microRNA-29a promotes angiogenesis through targeting the phosphatase and tensin homolog in endothelium. J. Biol. Chem., 2013, 288(15), 10418-10426.
103. Liu, S.; Sun, J.; Lan, Q. Glioblastoma microvesicles promote endothelial cell proliferation through Akt/beta-catenin pathway. Int. J. Clin. Exp. Pathol., 2014, 7(8), 4857-4866.
104. Forsyth, P.A.; Wong, H.; Laing, T.D.; Rewcastle, N.B.; Morris, D.G.; Muzik, H.; Leco, K.J.; Johnston, R.N.; Brasher, P.M.; Sutherland, G.; Edwards, D.R. Gelatinase-A (MMP-2), gelatinase-B (MMP-9) and membrane type matrix metalloproteinase-1 (MT1-MMP) are involved in different aspects of the pathophysiology of malignant gliomas. Br. J. Cancer, 1999, 79(11-12), 1828-1835.
105. Nakada, M.; Okada, Y.; Yamashita, J. The role of matrix metalloproteinases in glioma invasion. Front Biosci., 2003, 8, e261-269.
106. Dunlap, S.M.; Celestino, J.; Wang, H.; Jiang, R.; Holland, E.C.; Fuller, G.N.; Zhang, W. Insulin-like growth factor binding protein 2 promotes glioma development and progression. Proc. Natl. Acad. Sci. USA, 2007, 104(28), 11736-11741.
107. Edwards, L.A.; Woolard, K.; Son, M.J.; Li, A.; Lee, J.; Ene, C.; Mantey, S.A.; Maric, D.; Song, H.; Belova, G.; Jensen, R.T.; Zhang, W.; Fine, H.A. Effect of brain-and tumor-derived connective tissue growth factor on glioma invasion. J. Natl. Cancer Inst., 2011, 103(15), 1162-1178.
108. Arscott, W.T.; Tandle, A.T.; Zhao, S.; Shabason, J.E.; Gordon, I.K.; Schlaff, C.D.; Zhang, G.; Tofilon, P.J.; Camphausen, K.A. Ionizing radiation and glioblastoma exosomes: implications in tumor biology and cell migration. Transl. Oncol., 2013, 6(6), 638-648.
109. Yang, M.; Li, Y.; Chilukuri, K.; Brady, O.A.; Boulos, M.I.; Kappes, J.C.; Galileo, D.S. L1 stimulation of human glioma cell motility correlates with FAK activation. J. Neurooncol., 2011, 105(1), 27-44.
110. Kiefel, H.; Bondong, S.; Hazin, J.; Ridinger, J.; Schirmer, U.; Riedle, S.; Altevogt, P. L1CAM: a major driver for tumor cell invasion and motility. Cell. Adh. Migr., 2012, 6(4), 374-84.
111. Graner, M.W.; Alzate, O.; Dechkovskaia, A.M.; Keene, J.D.; Sampson, J.H.; Mitchell, D.A.; Bigner, D.D. Proteomic and immunologic analyses of brain tumor exosomes. FASEB J., 2009, 23(5), 1541-1557.
112. de Vrij, J.; Maas, S.L.; Kwappenberg, K.M.; Schnoor, R.; Kleijn, A.; Dekker, L.; Luider TM.; de Witte, L.D.; Litjens M.; van Strien, M.E.; Hol, E.M.; Kroonen, J.; Robe, P.A.; Lamfers, M.L.; Schilham, M.W.; Broekman, M.L. Glioblastoma-derived extracellular vesicles modify the phenotype of monocytic cells. Int. J. Cancer, 2015, 137(7), 1630-1642.
113. Al-Nedawi, K.; Meehan, B.; Micallef, J.; Lhotak, V.; May, L.; Guha, A.; Rak, J. Intercellular transfer of the oncogenic receptor EGFRvIII by microvesicles derived from tumour cells. Nat. Cell. Biol., 2008, 10(5), 619-624.
114. Demory Beckler, M.; Higginbotham, J.N.; Franklin, J.L.; Ham, A.J.; Halvey, P.J.; Imasuen, I.E.; Whitwell, C.; Li, M.; Liebler, D.C.; Coffey, R.J. Proteomic analysis of exosomes from mutant KRAS colon cancer cells identifies intercellular transfer of mutant KRAS. Mol. Cell. Proteomics, 2013, 12(2), 343-355.
115. Giusti, I.; D’Ascenzo, S.; Dolo, V. Microvesicles as potential ovarian cancer biomarkers. Biomed. Res. Int., 2013, 2013, 703048.
116. Giusti, I.; Dolo, V. Extracellular vesicles in prostate cancer: new future clinical strategies? Biomed. Res. Int., 2014, 2014, 561571.
117. Preusser, M.; de Ribaupierre, S.; Wohrer, A.; Erridge, S.C.; Hegi, M.; Weller, M.; Stupp, R. Current concepts and management of glioblastoma. Ann. Neurol., 2011, 70(1), 9-21.
118. Santiago-Dieppa, D.R.; Steinberg, J.; Gonda, D.; Cheung, V.J.; Carter, B.S.; Chen, C.C. Extracellular vesicles as a platform for ’liquid biopsy’ in glioblastoma patients. Expert Rev. Mol. Diagn., 2014, 14(7), 819-825.
119. Shao, H.; Chung, J.; Balaj, L.; Charest, A.; Bigner, D.D.; Carter, B.S.; Hochberg, F.H.; Breakefield, X.O.; Weissleder, R.; Lee, H. Protein typing of circulating microvesicles allows real-time monitoring of glioblastoma therapy. Nat. Med. 2012, 18(12), 1835-1840.
120. Taylor, D.D., Gercel-Taylor, C. MicroRNA signatures of tumor derived exosomes as diagnostic biomarkers of ovarian cancer. Gynecol. Oncol., 2008, 110(1), 13-21.
121. Chen, W.W.; Balaj, L.; Liau, L.M.; Samuels, M.L.; Kotsopoulos, S.K.; Maguire, C.A.; Loguidice, L.; Soto, H.; Garrett, M.; Zhu, L.D.; Sivaraman, S.; Chen, C.; Wong, E.T.; Carter, B.S.; Hochberg, F.H.; Breakefield, X.O.; Skog, J. BEAMing and Droplet Digital PCR Analysis of Mutant IDH1 mRNA in Glioma Patient Serum and Cerebrospinal Fluid Extracellular Vesicles. Mol. Ther. Nucleic. Acids, 2013, 2, e109.
122. Crowley, E.; Di Nicolantonio, F.; Loupakis, F.; Bardelli, A. Liquid biopsy: monitoring cancer-genetics in the blood. Nat. Rev. Clin. Oncol., 2013, 10(8), 472-484.
123. Janga, S.C.; Vallabhaneni, S. MicroRNAs as post-transcriptional machines and their interplay with cellular networks. Adv. Exp. Med. Biol., 2011, 722, 59-74.
124. Li, L.; Zhu, D.; Huang, L.; Zhang, J.; Bian, Z.; Chen, X.; Liu, Y.; Zhang, C.Y.; Zen, K. Argonaute 2 complexes selectively protect the circulating microRNAs in cell-secreted microvesicles. PLoS One., 2012, 7(10), e46957.
125. Izumiya, M.; Tsuchiya, N.; Okamoto, K.; Nakagama, H. Systematic exploration of cancer-associated microRNA through functional screening assays. Cancer Sci., 2011, 102(9), 1615-1621.
126. Chan, J.A.; Krichevsky, A.M.; Kosik, K.S. MicroRNA-21 is an antiapoptotic factor in human glioblastoma cells. Cancer Res., 2005, 65(14), 6029-6033.
127. Teplyuk, N.M.; B.; Gabriely, G.; Giese, A.; Kim, E.; Smolsky, M.; Kim, R.Y.; Saria, M.G.; Pastorino, S.; Kesari, S.; Krichevsky, A.M. MicroRNAs in cerebrospinal fluid identify glioblastoma and metastatic brain cancers and reflect disease activity. Neuro. Oncol., 2012, 14(6), 689-700.
128. Gan, H.K.; Cvrljevic, A.N.; Johns, T.G. The epidermal growth factor receptor variant III (EGFRvIII): where wild things are altered. FEBS J., 2013, 280(21), 5350-5370.
129. Turcan, S.; Rohle, D.; Goenka, A.; Walsh, L.A.; Fang, F.; Yilmaz, E.; Campos, C.; Fabius, A.W.; Lu, C.; Ward, P.S.; Thompson, C.B.; Kaufman, A.; Guryanova, O.; Levine, R.; Heguy, A.; Viale, A.; Morris, L.G.; Huse, J.T.; Mellinghoff, I.K.; Chan, T.A. IDH1 mutation is sufficient to establish the glioma hypermethylator phenotype. Nature, 483(7390), 479-83.
130. Verhaak, R.G.; Hoadley, K.A.; Purdom, E.; Wang, V.; Qi, Y.; Wilkerson, M.D.; Miller, C.R.; Ding, L.; Golub, T.; Mesirov, J.P.; Alexe, G.; Lawrence, M.; O’Kelly, M.; Tamayo, P.; Weir, B.A.; Gabriel, S.; Winckler, W.; Gupta, S.; Jakkula, L.; Feiler, H.S.; Hodgson, J.G.; James, C.D.; Sarkaria, J.N.; Brennan, C.; Kahn, A.; Spellman, P.T.; Wilson, R.K.; Speed, T.P.; Graym J.W.; Meyerson, M.; Getz, G.; Perou, C.M.; Hayes, D.N. Cancer Genome Atlas Research Network. Integrated genomic analysis identifies clinically relevant subtypes of glioblastoma characterized by abnormalities in PDGFRA, IDH1, EGFR, and NF1. Cancer Cell., 2010, 17(1), 98-110.
131. SongTao, Q.; Lei, Y.; Si, G.; YanQing, D.; HuiXia, H.; XueLin, Z.; LanXiao, W.; Fei Y. IDH mutations predict longer survival and response to temozolomide in secondary glioblastoma. Cancer Sci., 2012, 103(2), 269-273.
132. Bu, N.; Wu, H.; Sun, B.; Zhang, G.; Zhan, S.; Zhang, R.; Zhou, L. Exosome-loaded dendritic cells elicit tumor-specific CD8+ cytotoxic T cells in patients with glioma. J. Neurooncol., 2011, 104(3), 659-667.
133. Yu, J.S.; Wheeler, C.J.; Zeltzer, P.M.; Ying, H.; Finger, D.N.; Lee, P.K.; Yong, W.H F.; Thompson R.C.; Riedinger, M.S.; Zhang, W.; Prins, R.M.; Black K.L. Vaccination of malignant glioma patients with peptide pulsed dendritic cells elicits systemic cytotoxicity and intracranial T-cell infiltration. Cancer Res., 2001, 61(3), 842-847.
134. Insug, O.; Ku, G.; Ertl, H.C.; Blaszczyk-Thurin, M. A dendritic cell vaccine induces protective immunity to intracranial growth of glioma. Anticancer Res., 2002, 22(2A), 613-621.
135. Chaput, N.; Taieb, J.; Schartz, N.E.; Andre, F.; Angevin, E.; Zitvogel, L. Exosome-based immunotherapy. Cancer Immunol. Immunother., 2004, 53(3), 234-239.
136. Andre, F.; Chaput, N.; Schartz, N.E.; Flament, C.; Aubert, N.; Bernard, J.; Lemonnier, F.; Raposo, G.; Escudier, B.; Hsu, D.H.; Tursz, T.; Amigorena, S.; Angevin, E.; Zitvogel, L. Exosomes as potent cell-free peptide-based vaccine. I. Dendritic cell-derived exosomes transfer functional MHC class I/peptide complexes to dendritic cells. J. Immunol., 2004, 172(4), 2126-2136.
137. Zitvogel L.; Regnault A.; Lozier A.; Wolfers J.; Flament C.; Tenza D.; Ricciardi-Castagnoli P.; Raposo G.; Amigorena S. Eradication of established murine tumors using a novel cell-free vaccine dendritic cell-derived exosomes. Nat. Med., 1998, 4(5), 594-600.
138. Wolfers, J.; Lozier, A.; Raposo, G.; Regnault, A.; Thery, C.; Masurier, C.; Flament, C.; Pouzieux, S.; Faure, F.; Tursz, T.; Angevin, E.; Amigorena, S.; Zitvogel, L. Tumor-derived exosomes are a source of shared tumor rejection antigens for CTL crosspriming. Nat. Med., 2001, 7(3), 297-303.
139. Harshyne, L.A.; Hooper, K.M.; Andrews, E.G.; Nasca, B.J.; Kenyon, L.C.; Andrews, D.W.; Hooper, D.C. Glioblastoma exosomes and IGF-1R/AS-ODN are immunogenic stimuli in a translational research immunotherapy paradigm. Cancer Immunol. Immunother., 2015, 64(3), 299-309.
140. Muller, L.; Muller-Haegele, S.; Mitsuhashi, M.; Gooding, W.; Okada, H.; Whiteside, T.L. Exosomes isolated from plasma of glioma patients enrolled in a vaccination trial reflect antitumor immune activity and might predict survival. Oncoimmunology, 2015, 4(6): e1008347.
141. Nduom, E.K.; Yang, C.; Merrill, M.J.; Zhuang, Z.; Lonser, R.R. Characterization of the blood-brain barrier of metastatic and primary malignant neoplasms. J. Neurosurg., 2013, 119(2), 427-433.
142. Munoz, J.L.; Bliss, S.A.; Greco, S.J.; Ramkissoon, S.H.; Ligon, K.L.; Rameshwar, P. Delivery of Functional Anti-miR-9 by Mesenchymal Stem Cell-derived Exosomes to Glioblastoma Multiforme Cells Conferred Chemosensitivity. Mol. Ther. Nucleic Acids, 2013, 2, e126.